239 related articles for article (PubMed ID: 24991014)
21. A role for Ifit2 in restricting West Nile virus infection in the brain.
Cho H; Shrestha B; Sen GC; Diamond MS
J Virol; 2013 Aug; 87(15):8363-71. PubMed ID: 23740986
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
Ahmed M; Cramer SD; Lyles DS
Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
[TBL] [Abstract][Full Text] [Related]
23. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
Doll SC; Johnson TC
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of Zebrafish to Vesicular Stomatitis Virus Infection.
Guerra-Varela J; Baz-Martínez M; Da Silva-Álvarez S; Losada AP; Quiroga MI; Collado M; Rivas C; Sánchez L
Zebrafish; 2018 Apr; 15(2):124-132. PubMed ID: 29304309
[TBL] [Abstract][Full Text] [Related]
25. The VSV matrix protein inhibits NF-κB and the interferon response independently in mouse L929 cells.
Marquis KA; Becker RL; Weiss AN; Morris MC; Ferran MC
Virology; 2020 Sep; 548():117-123. PubMed ID: 32838932
[TBL] [Abstract][Full Text] [Related]
26. T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection.
Moseman EA; Blanchard AC; Nayak D; McGavern DB
Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32503876
[TBL] [Abstract][Full Text] [Related]
27. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
Trottier MD; Palian BM; Reiss CS
Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
[TBL] [Abstract][Full Text] [Related]
28. INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : III. EFFECT OF AGE AND PATHWAY OF INFECTION ON THE CHARACTER AND LOCALIZATION OF LESIONS IN THE CENTRAL NERVOUS SYSTEM.
Sabin AB; Olitsky PK
J Exp Med; 1938 Jan; 67(2):201-28. PubMed ID: 19870715
[TBL] [Abstract][Full Text] [Related]
29. Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.
Obuchi M; Fernandez M; Barber GN
J Virol; 2003 Aug; 77(16):8843-56. PubMed ID: 12885903
[TBL] [Abstract][Full Text] [Related]
30. Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection.
Trottier MD; Lyles DS; Reiss CS
J Neurovirol; 2007 Oct; 13(5):433-45. PubMed ID: 17994428
[TBL] [Abstract][Full Text] [Related]
31. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein.
Stegelmeier AA; Chan L; Mehrani Y; Petrik JJ; Wootton SK; Bridle B; Karimi K
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882969
[TBL] [Abstract][Full Text] [Related]
33. Long-distance interferon signaling within the brain blocks virus spread.
van den Pol AN; Ding S; Robek MD
J Virol; 2014 Apr; 88(7):3695-704. PubMed ID: 24429359
[TBL] [Abstract][Full Text] [Related]
34. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors.
Fang X; Zhang S; Sun X; Li J; Sun T
Vaccine; 2012 Feb; 30(7):1313-21. PubMed ID: 22222871
[TBL] [Abstract][Full Text] [Related]
36. Leucine-rich repeat-containing G protein-coupled receptor 4 facilitates vesicular stomatitis virus infection by binding vesicular stomatitis virus glycoprotein.
Zhang N; Huang H; Tan B; Wei Y; Xiong Q; Yan Y; Hou L; Wu N; Siwko S; Cimarelli A; Xu J; Han H; Qian M; Liu M; Du B
J Biol Chem; 2017 Oct; 292(40):16527-16538. PubMed ID: 28842478
[TBL] [Abstract][Full Text] [Related]
37. Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner.
Linder A; Bothe V; Linder N; Schwarzlmueller P; Dahlström F; Bartenhagen C; Dugas M; Pandey D; Thorn-Seshold J; Boehmer DFR; Koenig LM; Kobold S; Schnurr M; Raedler J; Spielmann G; Karimzadeh H; Schmidt A; Endres S; Rothenfusser S
Front Immunol; 2021; 12():595390. PubMed ID: 33995343
[TBL] [Abstract][Full Text] [Related]
38. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
Weidner JM; Jiang D; Pan XB; Chang J; Block TM; Guo JT
J Virol; 2010 Dec; 84(24):12646-57. PubMed ID: 20943977
[TBL] [Abstract][Full Text] [Related]
39. Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State.
Kueck T; Bloyet LM; Cassella E; Zang T; Schmidt F; Brusic V; Tekes G; Pornillos O; Whelan SPJ; Bieniasz PD
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578292
[TBL] [Abstract][Full Text] [Related]
40. E3 ubiquitin ligase RNF114 promotes vesicular stomatitis virus replication via inhibiting type I interferon production.
Han W; Chen Q; Cui J; Zhao Y; Li M; Li X
Microb Pathog; 2022 Jun; 167():105569. PubMed ID: 35545202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
